Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Bimatoprost (0.3mg/ml) + Timolol (5mg/ml) Eye Drops
Therapeutic Category
Ophthalmology, Cardiology, Cardiovascular, Hypertension/ Blood Pressure
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
10ml
Price
₹0/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Optiprost T Eye Drop contains Bimatoprost 0.3mg/ml + Timolol 5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its precise combination ensures enhanced pressure control with long-term safety.
The eye drop works by increasing aqueous humor outflow through Bimatoprost and reducing aqueous humor production via Timolol, delivering comprehensive intraocular pressure management and protecting optic nerve health.
From a franchise perspective, Optiprost T Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, specialty ophthalmology clinics, and glaucoma care centers, ensuring consistent prescriptions and repeat sales.
Adding Optiprost T Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.
Common side effects may include eye redness, burning or stinging sensation, itching, blurred vision, or foreign body sensation. Rarely, systemic effects such as slow heart rate, fatigue, dizziness, or breathing difficulty may occur due to Timolol. Changes in eyelash growth or iris pigmentation may occur with prolonged use.
Optiprost T Eye Drop is indicated for the management of open-angle glaucoma and ocular hypertension in patients who do not achieve adequate pressure control with single-agent therapy. It helps reduce elevated intraocular pressure and protects against optic nerve damage under ophthalmologist supervision.
Use Optiprost T Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use with caution in patients with asthma, chronic obstructive pulmonary disease, or cardiac conditions. Inform your doctor immediately if breathing difficulty, vision changes, or severe eye irritation occurs.
Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This ophthalmic combination has strong demand in the glaucoma and ocular hypertension segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on chronic eye-care therapies.
Medical distributors and agencies can benefit from consistent long-term demand for management of glaucoma and elevated intraocular pressure (IOP), which requires continuous therapy. Bimatoprost increases aqueous humor outflow and helps reduce eye pressure Timolol reduces aqueous humor production Together, they provide dual-action IOP control, strengthening a reliable ophthalmology chronic-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this eye drop with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong ophthalmologist prescriptions, chronic disease repeat sales, long-term patient usage, stable demand, reliable supply chain support, and good margins in specialty eye-care products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.